Study: Risk-Benefit Assessment of Food

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
引用
收藏
页码:108 / 109
页数:2
相关论文
共 50 条
  • [41] A Risk-Benefit Assessment of Octreotide in the Treatment of Acromegaly
    Aart Jan van der Lely
    Wouter W. de Herder
    Steven W. J. Lamberts
    Drug Safety, 1997, 17 : 317 - 324
  • [42] A risk-benefit assessment of oxytocics in obstetric practice
    Winkler, M
    Rath, W
    DRUG SAFETY, 1999, 20 (04) : 323 - 345
  • [43] A Risk-Benefit Assessment of HIV Protease Inhibitors
    Graeme J. Moyle
    Brian G. Gazzard
    Drug Safety, 1999, 20 : 299 - 321
  • [44] A Risk-Benefit Assessment of Corticosteroids in the Management of Croup
    Robert W. Yates
    Iolo J. M. Doull
    Drug Safety, 1997, 16 : 48 - 55
  • [45] Clinical risk-benefit assessment of dopamine agonists
    Moeller, J. C.
    Eggert, K. M.
    Unger, M.
    Odin, P.
    Chaudhuri, K. R.
    Oertel, W. H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 15 - 23
  • [46] A risk-benefit assessment of mirtazapine in the treatment of depression
    Kasper, S
    PraschakRieder, N
    Tauscher, J
    Wolf, R
    DRUG SAFETY, 1997, 17 (04) : 251 - 264
  • [47] RISK-BENEFIT ASSESSMENT OF ANTICOAGULANT-THERAPY
    HARRINGTON, R
    ANSELL, J
    DRUG SAFETY, 1991, 6 (01) : 54 - 69
  • [48] A Risk-Benefit Assessment of Therapies for Premature Labour
    Kenneth Higby
    Cheryl R. Suiter
    Drug Safety, 1999, 21 : 35 - 56
  • [49] RISK-BENEFIT
    MCCLUNG, N
    JOURNAL OF AUTISM AND CHILDHOOD SCHIZOPHRENIA, 1978, 8 (01): : 107 - 108
  • [50] A risk-benefit assessment of therapies for premature labour
    Higby, K
    Suiter, CR
    DRUG SAFETY, 1999, 21 (01) : 35 - 56